Compare International Flavors & Fragrances Inc. Common Stock (IFF) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
International Flavors & Fragrances Inc. Common Stock vs Nuvation Bio Inc. Class A Common Stock — how do they compare? International Flavors & Fragrances Inc. Common Stock trades at $84.65 (market cap $21.46B), while Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B). The key difference: International Flavors & Fragrances Inc. Common Stock is far larger — about 12.5× Nuvation Bio Inc. Class A Common Stock's market cap, and International Flavors & Fragrances Inc. Common Stock pays a 1.9% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold International Flavors & Fragrances Inc. Common Stock for 0 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.
| IFF | NUVB | |
|---|---|---|
Market Cap | $21.46B | $1.71B |
Volume | 2,398,781 | 5,448,712 |
Sector | Basic Materials | Health |
52-Week High | $88.07 | $9.54 |
52-Week Low | $59.55 | $3.41 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $27.13B | $1.30B |
Dividend Yield | 1.9% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About International Flavors & Fragrances Inc. Common Stock
International Flavors & Fragrances develops ingredients and solutions used in food, beverages, personal care, home care, health, and biosciences applications. Its portfolio includes flavors, fragrances, cultures, enzymes, and nutrition ingredients.
Read more on IFF →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
